Skip to main content
Premium Trial:

Request an Annual Quote

Japan's NGK Licenses OGT's Oligo IP to Develop, Sell Microarrays

NEW YORK (GenomeWeb News) – Japan’s NGK Insulators has licensed from Oxford Gene Technology patents for oligonucleotide microarrays in order to manufacture its own arrays, OGT said today.
 
The Japanese company will make the arrays using a technology called Geneshot, which uses piezoelectric ceramic microactuators. NGK can sell these OEM and NGK-branded microarrays in Japan.
 
The license will remain valid for the patents’ lifetime.
 
Financial details were not disclosed.          

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.